Go premium today and get access to all the details and pitch decks

Flux Robotics

Direct Message
Website
Download Pitch Deck
September 29, 2024
Data is self reported
Flux Robotics' Flux 2 robot revolutionizes vascular stent implantation, cutting procedure time from 3 hours to 45 minutes, reducing radiation exposure, and saving up to $20K per patient. After successful animal trials, we seek $1.3M for pre-clinical trials, clinical team expansion, and US market entry. Join us!

Achievement

For this startup there is an actual piece of text here instead of this blurred text. It's available to active investors and investors on a paid plan.

Founded in

2021

Country

Netherlands

Industry

Hardware, Health, MedTech

Patent information

For this startup there is an actual piece of text here instead of this blurred text. It's available to active investors and investors on a paid plan.

Team

Number of founders

Some blurred text here

Number of employees

Founder backgrounds

Exit experience

Some blurred text here

Relevant industry experience

Some blurred text here

Previous startup experience

Some blurred text here

EUR / Erasmus MC or TUDelft relation

Some blurred text here

Graduation year from EUR, Erasmus MC or TUDelft

Some blurred text here

In the news

Investment details

Amount raising

1950000

Ownership founders

Some blurred text here

Lead investor

Some blurred text here

Current investors

Some blurred text here

Intended closing date

Some blurred text here

Fundraising status

Some blurred text here

Already committed

Some blurred text here

Revenue Metrics

Paying customers

Some blurred text here

Monthly active users

Some blurred text here

Flux Robotics

Direct Message
Download Pitch Deck
September 29, 2024
Data is self reported
Flux Robotics' Flux 2 robot revolutionizes vascular stent implantation, cutting procedure time from 3 hours to 45 minutes, reducing radiation exposure, and saving up to $20K per patient. After successful animal trials, we seek $1.3M for pre-clinical trials, clinical team expansion, and US market entry. Join us!

Achievement

- Successfull MVP built - Successfull animal trials Phase 1, showcasing feasibility and safety of our guidewires in a live pig - 4 KOLs on board to support us and advise us - 3 key advisors from Silicon Valley - Health-economic model validated and also a compelte reimbursement plan - FDA Q-submission started

Founded in

2021

Country

Netherlands

Province

Overijssel

Industry

Hardware, Health, MedTech

SDGs

Good health and well-being (SDG #3), Gender equality (SDG #5), Partnerships for the goals (SDG #17), Decent work and economic growth (SDG #8)

Patent information

Yes, a patent pending for our core technology and we plan to file more patents on our disposable tech in Q3 2025.

Team

Number of founders

2

Number of employees

Founder backgrounds

Exit experience

No

Relevant industry experience

Yes

Previous startup experience

Yes

Female founder

No

EUR / Erasmus MC or TUDelft relation

EUR EMC TUDelft

Graduation year from EUR, Erasmus MC or TUDelft

2021

In the news

Investment details

Amount raising

1950000

Ownership founders

60-69% owned by founders

Lead investor

No, only a potential co-investor who at this point would like to remain anonymous.

Current investors

EUR1000000 (Grants and subsidies of which EUR250000 is the NWO Take-Off 2 loan and EUR145000 is a SAFE agreement with Berkeley SkyDeck)

Intended closing date

Q2, 2025

Fundraising status

Actively fundraising (brand name visible)

Already committed

250000

Revenue Metrics

Monthly revenue

pre-revenue

Monthly growth

not growing

Paying customers

0

Monthly active users

4
Flux Robotics' Flux 2 robot revolutionizes vascular stent implantation, cutting procedure time from 3 hours to 45 minutes, reducing radiation exposure, and saving up to $20K per patient. After successful animal trials, we seek $1.3M for pre-clinical trials, clinical team expansion, and US market entry. Join us!
Direct MessageSend Message

Premium Details Available

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
blurred values
Growth rate month over month
blurred values
Monthly revenue context
blurred values
Number of paying customers
blurred values
Monthly active users
blurred values

INVESTMENTS

Do you have a lead investor?
blurred values
How much have you raised in the past?
blurred values
How much of this round already committed?
blurred values
When are you aiming to close this round?
blurred values

TEAM

How much time do the founders spend on the business?
blurred values
Is there a founder with previous co-founder / c-level at startup experience?
blurred values
Is there a founder with previous Sector Experience?
blurred values
Is there a founder with previous Exit Experience?
blurred values
What percentage of company is owned by founders?
blurred values
Is there a women founder with at least 5% of the shares?
blurred values
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
blurred values
Graduation year from EUR, Erasmus MC or TUDelft
blurred values

OTHER

Year founded
blurred values
Patent status
blurred values
Start your free trial today to explore this information.
Start Free Trial

Premium Details

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
pre-revenue
Growth rate month over month
not growing
Monthly revenue context
Number of paying customers
0
Monthly active users
4

INVESTMENTS

Do you have a lead investor?
No, only a potential co-investor who at this point would like to remain anonymous.
How much have you raised in the past?
EUR1000000 (Grants and subsidies of which EUR250000 is the NWO Take-Off 2 loan and EUR145000 is a SAFE agreement with Berkeley SkyDeck)
How much of this round already committed?
250000
When are you aiming to close this round?
Q2, 2025

TEAM

How much time do the founders spend on the business?
Is there a founder with previous co-founder / c-level at startup experience?
Yes
Is there a founder with previous Sector Experience?
Yes
Is there a founder with previous Exit Experience?
No
What percentage of company is owned by founders?
60-69% owned by founders
Is there a women founder with at least 5% of the shares?
No
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
Founder graduated from TU Delft, EUR or Erasmus MC
Graduation year from EUR, Erasmus MC or TUDelft
2021

OTHER

Year founded
2021
Patent status
Yes, a patent pending for our core technology and we plan to file more patents on our disposable tech in Q3 2025.

Basic details

Amount raising
1950000
Country
Netherlands
Industry
Hardware, Health, MedTech
Founders
linkedin profile of founderlinkedin profile of founderlinkedin profile of founder
Last updated:
September 29, 2024

Key Achievements

  • - Successfull MVP built - Successfull animal trials Phase 1, showcasing feasibility and safety of our guidewires in a live pig - 4 KOLs on board to support us and advise us - 3 key advisors from Silicon Valley - Health-economic model validated and also a compelte reimbursement plan - FDA Q-submission started

Contact this startup to discuss investments

Try it! It's free, no account needed.
This startup has indicated interest to meet with potential investors. If you are interested, please fill out the contact form below and your message will be forwarded to the startup.
Oops! Something went wrong while sending your message.

Provide anonymous feedback

Startups greatly benefit from honest feedback from investors, but rarely receive it for numerous reasons. You can anonymously provide feedback here.
Your name and email address is not shared with the startup, but needed to avoid misusage.
Oops! Something went wrong while sending your message.